Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTILS.L Share News (TILS)

  • There is currently no data for TILS

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

SMALL-CAP WINNERS & LOSERS: EnQuest falls on production output warning

Thu, 02nd Sep 2021 10:55

(Alliance News) - The following stocks are the leading risers and fallers among London Main Market small-caps on Thursday.

----------

SMALL-CAP - WINNERS

----------

Tiziana Life Sciences PLC, up 18% at 72.35 pence, 12-month range 46.44p-206.00p. The clinical stage biotechnology company alongside US peer Precision BioSciences announce an exclusive license agreement to evaluate Tiziana's Foralumab, an anti-CD3 monoclonal antibody in conjunction with allogeneic CAR T candidates for cancer treatment. The companies would explore Foralumab as an agent to induce tolerance of allogeneic CAR T cells to potentially improve the clinical outcome of CAR T cell therapy. Under the terms, Tiziana will receive upfront payment, certain milestone payments, and royalties for Foralumab.

----------

Gym Group PLC, up 3.4% at 292.58 pence, 12-month range 116.00p-317.50p. The no-frills gym chain reports rise in membership as restrictions ease. For the six months ended June 30, pretax loss barely narrows to GBP28.5 million from GBP28.6 million the year before, as administrations costs remain high at GBP54.6 million, and revenue declines 21% to GBP29.3 million from GBP37.3 million. However, membership numbers at the end of June rose to 730,000 from 698,000 a year prior. Looking ahead, membership numbers at the end of August dipped to 721,000 from June, but sees higher membership levels in September and October as students return to universities. "Despite the significant disruption caused by the pandemic, Gym Group is well placed to continue its steady recovery and plans for growth as it capitalises on a return to more normal activity," says Edison analyst Richard Finch.

----------

SMALL-CAP - LOSERS

----------

EnQuest, down 7.7% at 23.30p, 12-month range 8.67p-26.95p. The oil and gas firm reports narrowed first half loss, but warns full-year production will be at the lower end of the guidance range. For six months to June 30, its profit after tax narrowed to USD56.4 million from a USD472.4 million loss last year. Looking ahead, EnQuest sees 2021 average net production at the lower end of the guidance range of 46,000 barrels of oil equivalent per day and 52,000 boepd. This reflects expected performances at Magnus, the Greater Kittiwake Area and PM8/Seligi over the course of the second half of the year, it says.

----------

SDCL Energy Efficiency Income Trust PLC, down 3.7% at 113.17p, 12-month range 104.50p-119.00p. The investment company intends to raise GBP175 million via a share issue at 110.50p each, which is 6.0% discount to Wednesday's closing share price of 117.50p.

----------

By Arvind Bhunjun; arvindbhunjun@alliancenews.com

Copyright 2021 Alliance News Limited. All Rights Reserved.

More News
18 May 2021 21:38

IN BRIEF: Tiziana Life Sciences annual loss widens

IN BRIEF: Tiziana Life Sciences annual loss widens

Read more
5 May 2021 19:20

TRADING UPDATES: SIG in good start to 2021; Accsys taps EUR37 million

TRADING UPDATES: SIG in good start to 2021; Accsys taps EUR37 million

Read more
13 Apr 2021 21:56

TRADING UPDATES: Clipper Logistics, JD Sports ink letter of intent

TRADING UPDATES: Clipper Logistics, JD Sports ink letter of intent

Read more
30 Mar 2021 20:34

IN BRIEF: Tiziana plans phase II trials for nasal Covid-19 treatment

IN BRIEF: Tiziana plans phase II trials for nasal Covid-19 treatment

Read more
5 Feb 2021 12:28

EXECUTIVE CHANGES: Iconic Labs CEO; Tiziana Hires Executive Director

EXECUTIVE CHANGES: Iconic Labs CEO; Tiziana Hires Executive Director

Read more
2 Feb 2021 11:35

Tiziana Surges As Nasal Therapy May Be Effective In New Virus Variants

Tiziana Surges As Nasal Therapy May Be Effective In New Virus Variants

Read more
27 Jan 2021 14:22

IN BRIEF: Tiziana Files US Statement Over USD250 Million Of Securities

IN BRIEF: Tiziana Files US Statement Over USD250 Million Of Securities

Read more
13 Jan 2021 16:21

UK EXECUTIVE CHANGE SUMMARY: Ex-Savills CEO To Be Tritax Big Box Chair

UK EXECUTIVE CHANGE SUMMARY: Ex-Savills CEO To Be Tritax Big Box Chair

Read more
7 Jan 2021 16:02

UK EXECUTIVE CHANGE SUMMARY: Premier Oil And DP Poland Board Changes

UK EXECUTIVE CHANGE SUMMARY: Premier Oil And DP Poland Board Changes

Read more
4 Jan 2021 15:19

Tiziana completes Covid-19 study in Brazil

(Sharecast News) - Biotechnology company Tiziana Life Sciences announced the completion of its clinical study in Brazil on Monday, investigating nasally-administered Foralumab - its proprietary human monoclonal antibody - either alone or in combination with orally administered dexamethasone in Covid-19 patients.

Read more
4 Jan 2021 12:16

LONDON MARKET MIDDAY: Vaccine Rollouts, M&A And Gold Surge Boost FTSE

LONDON MARKET MIDDAY: Vaccine Rollouts, M&A And Gold Surge Boost FTSE

Read more
4 Jan 2021 12:15

Tiziana Announces Foralumab Trial Completion For Covid-19 Treatment

Tiziana Announces Foralumab Trial Completion For Covid-19 Treatment

Read more
4 Jan 2021 10:44

UK WINNERS & LOSERS SUMMARY: Tui Rises As Tips "Normal" Summer Trading

UK WINNERS & LOSERS SUMMARY: Tui Rises As Tips "Normal" Summer Trading

Read more
17 Dec 2020 19:37

UK TRADING UPDATE SUMMARY: Polar Capital Adds GBP1.2 Billion To Assets

UK TRADING UPDATE SUMMARY: Polar Capital Adds GBP1.2 Billion To Assets

Read more
10 Dec 2020 15:30

UK DIRECTOR DEALINGS SUMMARY: IG Design CEO Sells GBP528,000 In Shares

UK DIRECTOR DEALINGS SUMMARY: IG Design CEO Sells GBP528,000 In Shares

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.